Literature DB >> 9815002

Counterregulatory hormones oscillate during steady-state hypoglycemia.

P Genter1, N Berman, M Jacob, E Ipp.   

Abstract

During hypoglycemia, the magnitude of the counterregulatory response depends on the extent of plasma glucose reduction. However, our clinical observations during steady-state hypoglycemia indicate that symptom severity can change independently of plasma glucose concentrations, i.e., symptoms appeared to fluctuate despite stable glucose levels. This study was therefore designed to test the hypothesis that hormonal and symptomatic responses to hypoglycemia are pulsatile. Seven healthy subjects had serial blood sampling at 3-min intervals during 90 min of insulin-induced hypoglycemia. Mean +/- SE plasma glucose levels plateaued at 62 +/- 3 mg/dl. Counterregulatory hormones were significantly elevated (P < 0.05-0. 01, except norepinephrine) and strikingly pulsatile. Cluster analysis revealed pulses of large magnitude in plasma glucagon, epinephrine, and norepinephrine concentrations. Amplitudes were, respectively, 72 +/- 4, 64 +/- 8, and 48 +/- 3% of the mean. Interpeak intervals were 27 +/- 7, 19 +/- 4, and 25 +/- 5 min, respectively. Symptom score and cardiovascular responses were also pulsatile; their peaks were found to coincide with epinephrine peaks. We conclude that hormonal and symptomatic counterregulation in hypoglycemia, while critically driven by plasma glucose levels, is also influenced by an endogenous pulsatility that exists despite steady-state glucose concentrations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815002     DOI: 10.1152/ajpendo.1998.275.5.E821

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  J Diabetes Sci Technol       Date:  2009-01

3.  Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

Review 4.  Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.

Authors:  L S Farhy; A L McCall
Journal:  Diabetes Obes Metab       Date:  2011-10       Impact factor: 6.577

5.  Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.

Authors:  Leon S Farhy; Zhongmin Du; Qiang Zeng; Paula P Veldhuis; Michael L Johnson; Kenneth L Brayman; Anthony L McCall
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

6.  Pancreatic network control of glucagon secretion and counterregulation.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

7.  Modeling the autonomic and metabolic effects of obstructive sleep apnea: a simulation study.

Authors:  Limei Cheng; Michael C K Khoo
Journal:  Front Physiol       Date:  2012-01-04       Impact factor: 4.566

Review 8.  Heterogeneity and emergent behaviour in the vascular endothelium.

Authors:  John G McCarron; Calum Wilson; Helen R Heathcote; Xun Zhang; Charlotte Buckley; Matthew D Lee
Journal:  Curr Opin Pharmacol       Date:  2019-04-18       Impact factor: 5.547

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.